NeuroOne Medical Technologies Corporation NMTC 深 沪
已收盘 08-15 16:00:00 美东时间
0.8198
-0.010
-1.23%
华盛通- 最 高0.87
- 今 开0.821
- 成交量 9.47万股
- 最 低 0.8101
- 昨 收 0.83
- 总市值 4084.06万
- 52周最高 1.39
- 市盈率 静 --
- 换手率 0.19%
- 52周最低 0.3954
- 委 比 88.26%
- 总股本 4981.78万
- 历史最高 7.97
- 量 比 0.46
- 振 幅 7.22%
- 历史最低 0.3954
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NeuroOne Updates Prospectus for $6.75 Million Offering
NeuroOne Medical Technologies ( ($NMTC) ) has provided an update. On December 2...
08-16 04:58
NeuroOne Medical Technologies shares are trading lower after the company reported a Q2 sales miss.
NeuroOne Medical Technologies shares are trading lower after the company report...
08-15 01:30
NeuroOne Medical Tech Affirms FY2025 Sales Guidance of $8.00M-$10.00M vs $8.71M Est
NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million to $8.00 million-$10.00 million vs $8.71 million estimate.
08-14 19:36
NeuroOne Medical Tech Q3 EPS $(0.03) Beats $(0.05) Estimate, Sales $1.70M Miss $1.82M Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 70 percent increase over losses of $(0.10) per share from
08-14 19:31
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
NeuroOne Medical Technologies Corporation will release its Q3 2025 financial results on August 14, 2025, before market open. A conference call and webcast will be held at 8:30 a.m. Eastern time on the same day to discuss the results. Participants can join via phone or webcast using the provided details. A replay will be available until August 28, 2025. The company specializes in minimally invasive and high-definition solutions for neurological di...
07-31 12:30
NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office
NeuroOne Medical Technologies Corporation has received a notice of allowance for a strategic U.S. patent application focused on novel methods for making neural probe devices. This patent covers electrode material deposition, enhancing the functionality and profile of their electrodes. With this addition, their portfolio includes 17 issued and pending patents on thin-film electrode technologies. The Company aims to advance its technology platform ...
07-23 12:30
NeuroOne Medical Technologies Patient Treated With Patented OneRF Ablation System Surpasses One Year Milestone Of Being Seizure Free
Patient Treated with OneRF® Ablation System Previously Experienced up to 10 Seizures a DayEDEN PRAIRIE, Minn., June 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or
06-23 20:43
NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System
NeuroOne Medical Technologies announced that Clara, a patient treated with their OneRF® Ablation System, has remained seizure-free for over a year. Clara, who previously experienced up to 10 seizures daily, has seen a significant improvement in her quality of life since the procedure in June 2024. The OneRF® System, which is FDA-cleared, uses the same sEEG electrode for both diagnosis and therapy, allowing ablation to be performed at the patient’...
06-23 12:30
